Study of Lyme Neuroborreliosis

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The main purpose of this study is to determine whether four weeks treatment with oral doxycycline is as equally effective as three weeks treatment with intravenous ceftriaxone in patients with Lyme neuroborreliosis. The other purpose is to improve laboratory diagnostics of Lyme neuroborreliosis and further define the manifestations and epidemiology of the disease in Finland.

See also
Status	Clinical Trial	Phase
Terminated	`NCT04577053` - PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics	N/A
Completed	`NCT00138801` - Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis	Phase 3
Not yet recruiting	`NCT03820999` - An Intervention in a Primary Healthcare Setting to Reduce Lyme Neuroborreliosis Treatment Delay	N/A
Completed	`NCT00037479` - Brain Imaging and Retreatment Study of Persistent Lyme Disease	Phase 2

NCT number	NCT01635530
Study type	Interventional
Source	Turku University Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	August 2012
Completion date	December 31, 2018

Study of Lyme Neuroborreliosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms